» Authors » K Cahill

K Cahill

Explore the profile of K Cahill including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 463
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hearn N, Atwell D, Cahill K, Elks J, Vignarajah D, Lagopoulos J, et al.
Clin Oncol (R Coll Radiol) . 2020 Jul; 33(1):e1-e14. PMID: 32669228
Aims: Improving pathological complete response (pCR) rates after neoadjuvant chemoradiotherapy for locally advanced rectal cancer may facilitate surgery-sparing treatment paradigms. Radiotherapy boost has been linked to higher rates of pCR;...
2.
Atwell D, Elks J, Cahill K, Hearn N, Vignarajah D, Lagopoulos J, et al.
Clin Oncol (R Coll Radiol) . 2020 Jan; 32(5):330-341. PMID: 31911016
The management of head and neck cancer is complex and often involves multimodality treatment. Certain groups of patients, such as those with inoperable or advanced disease, are at higher risk...
3.
Bavbek S, Aydin O, Ataman S, Cahill K, Castells M
Allergy . 2011 Apr; 66(9):1256-7. PMID: 21507006
No abstract available.
4.
Cahill K
IET Syst Biol . 2010 Nov; 4(6):367-78. PMID: 21073236
Certain short polycations, such as trans-activating transcriptional activator and oligoarginine, rapidly pass through the plasma membranes of mammalian cells by a mechanism called transduction, as well as by endocytosis and...
5.
Cahill K
IET Syst Biol . 2010 Oct; 3(5):300-6. PMID: 21028921
Cell-penetrating peptides (CPPs) such as HIV's trans-activating transcriptional activator (TAT) and polyarginine rapidly pass through the plasma membranes of mammalian cells by an unknown mechanism called transduction. They may be...
6.
Bala M, Strzeszynski L, Cahill K
Cochrane Database Syst Rev . 2008 Feb; (1):CD004704. PMID: 18254058
Background: Mass media tobacco control campaigns can reach large numbers of people. Much of the literature is focused on the effects of tobacco control advertising on young people, but there...
7.
Cahill K, Ussher M
Cochrane Database Syst Rev . 2007 Oct; (4):CD005353. PMID: 17943852
Background: Rimonabant is a selective type 1 cannabinoid (CB1) receptor antagonist. It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by...
8.
Cahill K, Ussher M
Cochrane Database Syst Rev . 2007 Jul; (3):CD005353. PMID: 17636794
Background: Rimonabant is a selective type 1 cannabinoid (CB1) receptor antagonist. It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by...
9.
Cahill K, Stead L, Lancaster T
Cochrane Database Syst Rev . 2007 Jan; (1):CD006103. PMID: 17253581
Background: Nicotine receptor partial agonists may help smokers to quit by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking...
10.
Shabbir J, McDonnell C, OSullivan J, Cahill K, Moore A, Raminlagan R, et al.
Ir J Med Sci . 2004 Nov; 173(2):102-4. PMID: 15540714
Background: According to a recent study in Cardiff, the incidence of stab wounds is 14 per 100,000 population per annum. No such figures are available for Ireland. Aim: To evaluate...